Mayo CALR mutation type classification guide using alpha helix propensity

被引：22

作者：

Lasho, Terra L. ^{[1
]}

Finke, Christy M. ^{[1
]}

Tischer, Alexander ^{[1
]}

Pardanani, Animesh ^{[1
]}

Tefferi, Ayalew ^{[1
]}

机构：

[1] Mayo Clin, Div Hematol, Dept Internal Med, Rochester, MN 55905 USA

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2018年 / 93卷 / 05期

关键词：

CALRETICULIN MUTATIONS; PRIMARY MYELOFIBROSIS; PROGNOSTIC IMPACT; 1-LIKE;

D O I：

10.1002/ajh.25065

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E128 / E129

页数：2

共 9 条

[1] The different prognostic impact of type-1 or type-1 like and type-2 or type-2 like CALR mutations in patients with primary myelofibrosis [J].

不详 .

AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (07) :E320-E321

[2]

[Anonymous], 2017, WHO CLASSIFICATION T

[3] Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution [J].

Cabagnols, X. ;

Defour, J. P. ;

Ugo, V. ;

Ianotto, J. C. ;

Mossuz, P. ;

Mondet, J. ;

Girodon, F. ;

Alexandre, J. H. ;

Mansier, O. ;

Viallard, J. F. ;

Lippert, E. ;

Murati, A. ;

Mozziconacci, M. J. ;

Saussoy, P. ;

Vekemans, M. C. ;

Knoops, L. ;

Pasquier, F. ;

Ribrag, V. ;

Solary, E. ;

Plo, I. ;

Constantinescu, S. N. ;

Casadevall, N. ;

Vainchenker, W. ;

Marzac, C. ;

Bluteau, O. .

LEUKEMIA, 2015, 29 (01) :249-252

[4] Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis [J].

Guglielmelli, P. ;

Rotunno, G. ;

Fanelli, T. ;

Pacilli, A. ;

Brogi, G. ;

Calabresi, L. ;

Pancrazzi, A. ;

Vannucchi, A. M. .

BLOOD CANCER JOURNAL, 2015, 5 :e360-e360

[5] MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis [J].

Guglielmelli, Paola ;

Lasho, Terra L. ;

Rotunno, Giada ;

Mudireddy, Mythri ;

Mannarelli, Carmela ;

Nicolosi, Maura ;

Pacilli, Annalisa ;

Pardanani, Animesh ;

Rumi, Elisa ;

Rosti, Vittorio ;

Hanson, Curtis A. ;

Mannelli, Francesco ;

Ketterling, Rhett P. ;

Gangat, Naseema ;

Rambaldi, Alessandro ;

Passamonti, Francesco ;

Barosi, Giovanni ;

Barbui, Tiziano ;

Cazzola, Mario ;

Vannucchi, Alessandro M. ;

Tefferi, Ayalew .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04) :310-+

[6] Type 1 vs type 2 calreticulin mutations in primary myelofibrosis: differences in phenotype and prognostic impact [J].

Tefferi, A. ;

Lasho, T. L. ;

Finke, C. ;

Belachew, A. A. ;

Wassie, E. A. ;

Ketterling, R. P. ;

Hanson, C. A. ;

Pardanani, A. .

LEUKEMIA, 2014, 28 (07) :1568-1570

[7] Myeloproliferative neoplasms: A decade of discoveries and treatment advances [J].

Tefferi, Ayalew .

AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (01) :50-58

[8] The prognostic advantage of calreticulin mutations in myelofibrosis might be confined to type 1 or type 1-like CALR variants [J].

Tefferi, Ayalew ;

Lasho, Terra L. ;

Tischer, Alexander ;

Wassie, Emnet A. ;

Finke, Christy M. ;

Belachew, Alem A. ;

Ketterling, Rhett P. ;

Hanson, Curtis A. ;

Pardanani, Animesh D. .

BLOOD, 2014, 124 (15) :2465-2466

[9] Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: A collaborative study of 1027 patients [J].

Tefferi, Ayalew ;

Wassie, Emnet A. ;

Guglielmelli, Paola ;

Gangat, Naseema ;

Belachew, Alem A. ;

Lasho, Terra L. ;

Finke, Christy ;

Ketterling, Rhett P. ;

Hanson, Curtis A. ;

Pardanani, Animesh ;

Wolanskyj, Alexandra P. ;

Maffioli, Margherita ;

Casalone, Rosario ;

Pacilli, Annalisa ;

Vannucchi, Alessandro M. ;

Passamonti, Francesco .

AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (08) :E121-E124

← 1 →